We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

62 hedge funds and large institutions have $275M invested in Immune Design Corp. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 3

386% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 7

31% more capital invested

Capital invested by funds: $210M → $275M (+$65.6M)

29% more funds holding

Funds holding: 4862 (+14)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
62
Holders Change
+14
Holders Change %
+29.17%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
34
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CGL
1
Column Group LP
California
$65.3M
PAI
2
ProQuest Associates IV
Florida
$41M -$10.2M -430,182 -18%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$32.6M +$17.1M +723,600 +84%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$23.3M +$10.1M +426,000 +61%
Franklin Resources
5
Franklin Resources
California
$17.3M +$2.05M +86,700 +12%
SAM
6
Sectoral Asset Management
Quebec, Canada
$16.7M +$17.6M +743,263 +1,107%
RIM
7
RS Investment Management
California
$15.5M +$5.38M +227,530 +44%
BFA
8
BlackRock Fund Advisors
California
$6.13M +$2.95M +124,699 +72%
PI
9
Putnam Investments
Massachusetts
$5.81M +$6.65M +281,531 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$5.39M +$4.26M +180,150 +222%
Jennison Associates
11
Jennison Associates
New York
$4.16M +$4.76M +201,459 New
CAM
12
Cormorant Asset Management
Massachusetts
$3.9M +$1.65M +70,000 +59%
BIT
13
BlackRock Institutional Trust
California
$3.42M +$2.16M +91,506 +124%
JP Morgan Chase
14
JP Morgan Chase
New York
$3.41M -$909K -38,466 -19%
BA
15
BlackRock Advisors
Delaware
$3.26M +$2.15M +90,972 +136%
IHM
16
Iguana Healthcare Management
New York
$3.1M +$1.18M +50,000 +50%
BBA
17
Baker Bros. Advisors
New York
$3.08M +$3.52M +148,937 New
SFM
18
Sphera Funds Management
Israel
$2.89M +$249K +10,560 +8%
EAM
19
Eventide Asset Management
Massachusetts
$2.13M +$495K +20,947 +26%
Northern Trust
20
Northern Trust
Illinois
$1.81M +$608K +25,755 +42%
State Street
21
State Street
Massachusetts
$1.77M +$288K +12,185 +16%
Marshall Wace
22
Marshall Wace
United Kingdom
$1.5M +$1.72M +72,812 New
PAMU
23
Pictet Asset Management (UK)
United Kingdom
$1.45M +$1.77M +75,100 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$1.15M +$492K +20,830 +60%
RSCM
25
Rock Springs Capital Management
Maryland
$1.14M +$1.3M +55,000 New

IMDZ Hedge Fund Activity: Q2 2015 in Review

62 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2015, worth a combined $275M — up 31% from $210M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IMDZ positions and 3 closed out — a net gain of 14 holders — while 34 added to existing stakes and 7 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $17.6M. The largest seller was ProQuest Associates IV, cutting an estimated $10.2M.

  • 62 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2015, up from 48 in Q1 2015.
  • Funds reported $275M of Immune Design Corp. stock for Q2 2015, up 31% quarter-over-quarter.
  • 17 funds opened new Immune Design Corp. positions in Q2 2015 and 3 closed out, a net change of +14 holders.
  • The largest Immune Design Corp. buyer in Q2 2015 was Sectoral Asset Management, an estimated $17.6M added.
  • The largest Immune Design Corp. seller in Q2 2015 was ProQuest Associates IV, an estimated $10.2M sold.

Based on aggregated 13F filings for Q2 2015.